Recordati
engages in the research, development, manufacture, marketing and sale of pharmaceutical drugs for the treatment of rare diseases... Read moreRecordati
engages in the research, development, manufacture, marketing and sale of pharmaceutical drugs for the treatment of rare diseases... Read more
News
Acquisition
Mar 31, 2026
Private Equity Insights
Recordati Was acquired by CVC Capital Partners plc for $12.6B
investment
Jan 06, 2026
https://www.prnewswire.com/news-releases/strmbio-raises-8-million-in-series-seed-2-financing-to-advance-non-viral-gene-delivery-platform-for-in-vivo-cell-engineering-and-gene-therapy-302654581.html
Recordati S.p.A. has invested $8M in STRM.BIO, Inc.
Recordati Competitors
1
2
3
4
5
6
7
8
9
10